echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > JCEM: Changes of visceral fat and whole body fat during transsexual human hormone therapy and its influence on cardiometabolic risk factors

    JCEM: Changes of visceral fat and whole body fat during transsexual human hormone therapy and its influence on cardiometabolic risk factors

    • Last Update: 2021-09-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Too much visceral fat increases type 2 diabetes and heart blood vessel disease risk and affected by sex hormones


    Diabetes, heart blood vessels





    Original source:

    Maartje Klaver.


    Change in visceral fat and total body fat and the effect on cardiometabolic risk factors during transgender hormone therapy

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.